EP2911684
IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES
:
EP einkaleyfi: Þýðing ekki lögð inn:
23.10.2013:
19.6.2019:
13849581.7
:
22.10.2033
:
IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES
23.10.2013
19.6.2019
:
NOVARTIS AG:
Lichtstrasse 35, 4056, Basel, CH
:
The United States of America, as represented by The Secretary, Department of Health and Human Services:
The Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, 20892-7660, Bethesda, MD, US
:
FELBER, Barbara, K.:
Rockville, MD, US
:
FINKIELSZTTEIN, Sergio:
Newton, MA, US
:
PAVLAKIS, George, N.:
Rockville, MD, US
:
VOURNAKIS, John, N.:
Charleston, SC, US
:
201261718169 P:
24.10.2012:
US
:
201361820035 P:
6.5.2013:
US
:
US2013066424:
23.10.2013
:
A61K 38/20, A61P 35/00, A61P 35/04, A61P 37/04